Millennium Management’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.7M Sell
1,135,756
-1,010,553
-47% -$18.4M 0.01% 1107
2025
Q1
$42.6M Buy
2,146,309
+986,776
+85% +$19.6M 0.02% 604
2024
Q4
$19.9M Buy
1,159,533
+42,603
+4% +$731K 0.01% 1103
2024
Q3
$22.3M Buy
1,116,930
+176,275
+19% +$3.52M 0.01% 1033
2024
Q2
$10.5M Sell
940,655
-769,366
-45% -$8.6M ﹤0.01% 1437
2024
Q1
$11.3M Sell
1,710,021
-1,741,846
-50% -$11.5M ﹤0.01% 1420
2023
Q4
$15.6M Sell
3,451,867
-642,373
-16% -$2.9M 0.01% 1184
2023
Q3
$14.7M Buy
4,094,240
+1,184,054
+41% +$4.24M 0.01% 1159
2023
Q2
$10.7M Sell
2,910,186
-2,463,315
-46% -$9.09M 0.01% 1411
2023
Q1
$17.8M Buy
5,373,501
+76,720
+1% +$254K 0.01% 1026
2022
Q4
$20.6M Buy
5,296,781
+3,569,778
+207% +$13.9M 0.01% 993
2022
Q3
$4.2M Sell
1,727,003
-4,162,968
-71% -$10.1M ﹤0.01% 2323
2022
Q2
$11.7M Buy
5,889,971
+2,531,272
+75% +$5.01M 0.01% 1358
2022
Q1
$6.15M Buy
3,358,699
+3,189,501
+1,885% +$5.84M ﹤0.01% 2085
2021
Q4
$239K Sell
169,198
-412,419
-71% -$583K ﹤0.01% 4559
2021
Q3
$657K Sell
581,617
-420,519
-42% -$475K ﹤0.01% 3976
2021
Q2
$1.6M Buy
+1,002,136
New +$1.6M ﹤0.01% 3342
2021
Q1
Sell
-52,264
Closed -$102K 4430
2020
Q4
$102K Buy
52,264
+20,517
+65% +$40K ﹤0.01% 3908
2020
Q3
$76 Sell
31,747
-291,080
-90% -$697 ﹤0.01% 3436
2020
Q2
$946K Buy
322,827
+128,725
+66% +$377K ﹤0.01% 2419
2020
Q1
$559K Sell
194,102
-71,999
-27% -$207K ﹤0.01% 2255
2019
Q4
$1.06M Sell
266,101
-596,418
-69% -$2.38M ﹤0.01% 2413
2019
Q3
$3.84M Buy
862,519
+743,506
+625% +$3.31M 0.01% 1643
2019
Q2
$461K Buy
+119,013
New +$461K ﹤0.01% 2793
2018
Q3
Sell
-229,416
Closed -$1.04M 3457
2018
Q2
$1.04M Sell
229,416
-44,205
-16% -$199K ﹤0.01% 2492
2018
Q1
$1.26M Buy
273,621
+206,088
+305% +$948K ﹤0.01% 2390
2017
Q4
$217K Buy
67,533
+48,455
+254% +$156K ﹤0.01% 3262
2017
Q3
$59K Buy
+19,078
New +$59K ﹤0.01% 3134